Tamura H, Sasaki K, Watahiki R
Department of Oral and Maxillofacial Surgery, Kameda General Hospital, 929, Higashi-cho, Kamogawa-city, Chiba 296-8602, Japan.
Bull Tokyo Dent Coll. 2000 Feb;41(1):21-4. doi: 10.2209/tdcpublication.41.21.
A case of maxillary carcinoma treated with primary insertion of Brånemark implants into the zygomatic bone following subtotal maxillectomy is reported. This method has several advantages. First, early detection of postoperative recurrence is easier than with closing the flap. Second, when the implant is inserted into the midfacial region, zygomatic bone can be useful because of thickness. In addition, applying a maxillary prosthesis in the early stages avoids contracture of facial soft tissue. This primary reconstructive method is effective in cases of preserved zygoma after total maxillectomy.
报道了1例上颌骨次全切除术后将Brånemark种植体直接植入颧骨治疗上颌癌的病例。该方法有几个优点。第一,与关闭皮瓣相比,术后复发的早期检测更容易。第二,当种植体植入面中部区域时,由于颧骨的厚度,颧骨会很有用。此外,早期应用上颌假体可避免面部软组织挛缩。这种一期重建方法在全上颌骨切除术后保留颧骨的病例中是有效的。